Skip to main content
Erschienen in: Journal of Cancer Survivorship 2/2015

01.06.2015

Effects of web-based intervention on risk reduction behaviors in melanoma survivors

verfasst von: Deborah J. Bowen, Wylie Burke, Jennifer L. Hay, Hendrika Meischke, Julie N Harris

Erschienen in: Journal of Cancer Survivorship | Ausgabe 2/2015

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Melanoma is the most severe form of skin cancer, and survivors of melanoma carry increased risk of additional melanoma diagnosis. Multiple methods exist for primary and secondary prevention of melanoma in survivors. This study tested a web-based family communication intervention to improve these preventive behaviors in melanoma families.

Methods

Families (a survivor, at least one first-degree relative and a parent) were randomized either to receive the intervention package or to serve as comparison families. We assessed melanoma prevention behaviors in each cohort member before and after the intervention. The intervention was a web-based multicomponent intervention focused on increasing family communication and exchange of risk information.

Results

Results indicated that, compared to comparison survivors, intervention survivors improved their skin self-examination and their sun protection behaviors significantly from before to after intervention.

Conclusion

These data support the use of web-based interventions for behavioral changes in survivors and allow for consideration of dissemination of this successful intervention. These data have implications for interventions that can help cancer families deal with issues of risk and illness.

Implications for cancer survivors

These data indicate that survivors can benefit from exposure to a website that helps direct their future health behaviors.
Literatur
2.
Zurück zum Zitat SEER Cancer Statistics Review, 1975–2010, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2010/, based on November 2012 SEER data submission, posted to the SEER web site, April 2013. Howlader N, Noone AM, Krapcho M, Garshell J, Neyman N, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z, Cho H, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975–2010, National Cancer Institute. Bethesda, MD, http://​seer.​cancer.​gov/​csr/​1975_​2010/​, based on November 2012 SEER data submission, posted to the SEER web site, April 2013. Howlader N, Noone AM, Krapcho M, Garshell J, Neyman N, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z, Cho H, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds).
3.
Zurück zum Zitat ASCO 2011 Abstract: LBA5 Phase 3 randomized study of ipilimumab (IPI) plus dacarbazine (DTIC) vs DTIC alone as first line treatment in patients with unresectable stage III or IV melanoma. Wolchok JD, Thomas L, Bondarenko IN, O’Day S, Weber JS, Garbe C, Francis S, Ibrahim RA, Hoos A, Robert C. ASCO 2011 Abstract: LBA5 Phase 3 randomized study of ipilimumab (IPI) plus dacarbazine (DTIC) vs DTIC alone as first line treatment in patients with unresectable stage III or IV melanoma. Wolchok JD, Thomas L, Bondarenko IN, O’Day S, Weber JS, Garbe C, Francis S, Ibrahim RA, Hoos A, Robert C.
4.
Zurück zum Zitat Coyte A, Morrison DS, McLoone P. Second primary cancer risk—the impact of applying different definitions of multiple primaries: results from a retrospective population-based cancer registry study. BMC Cancer. 2014. doi:10.1186/1471-2407-14-272.PubMedCentralPubMed Coyte A, Morrison DS, McLoone P. Second primary cancer risk—the impact of applying different definitions of multiple primaries: results from a retrospective population-based cancer registry study. BMC Cancer. 2014. doi:10.​1186/​1471-2407-14-272.PubMedCentralPubMed
5.
Zurück zum Zitat Begg CB, Hummer A, Mujumdar U, Armstrong BK, Kricker A, Marrett LD, et al. Familial aggregation of melanoma risks in a large population-based sample of melanoma cases. Cancer Causes Control. 2004. doi:10.1007/s10552-004-2474-1.PubMed Begg CB, Hummer A, Mujumdar U, Armstrong BK, Kricker A, Marrett LD, et al. Familial aggregation of melanoma risks in a large population-based sample of melanoma cases. Cancer Causes Control. 2004. doi:10.​1007/​s10552-004-2474-1.PubMed
6.
Zurück zum Zitat Swetter SM, Pollitt RA, Johnson TM, Brooks DR, Geller AC. Behavioral determinants of successful early melanoma detection: role of self and physician skin examination. Cancer. 2012. doi:10.1002/cncr.26707.PubMedCentral Swetter SM, Pollitt RA, Johnson TM, Brooks DR, Geller AC. Behavioral determinants of successful early melanoma detection: role of self and physician skin examination. Cancer. 2012. doi:10.​1002/​cncr.​26707.PubMedCentral
7.
Zurück zum Zitat Bichakjian CK, Halpern AC, Johnson TM, Hood AF, Grichnik J, Swetter SM, et al. Guidelines of care for the management of primary cutaneous melanoma. J Am Acad Dermatol. 2011. doi:10.1016/j.jaad.2011.04.031. Bichakjian CK, Halpern AC, Johnson TM, Hood AF, Grichnik J, Swetter SM, et al. Guidelines of care for the management of primary cutaneous melanoma. J Am Acad Dermatol. 2011. doi:10.​1016/​j.​jaad.​2011.​04.​031.
11.
12.
Zurück zum Zitat Oliveria SA, Shuk E, Hay JL, Heneghan M, Goulart JM, Panageas K, et al. Melanoma survivors: health behaviors, surveillance, psychosocial factors, and family concerns. Psycho-Oncology. 2013. doi:10.1002/pon.2059.PubMed Oliveria SA, Shuk E, Hay JL, Heneghan M, Goulart JM, Panageas K, et al. Melanoma survivors: health behaviors, surveillance, psychosocial factors, and family concerns. Psycho-Oncology. 2013. doi:10.​1002/​pon.​2059.PubMed
13.
14.
Zurück zum Zitat Gritz ER, Tripp MK, Peterson SK, Prokhorov AV, Shete SS, Urbauer DL, Fellman BM, J Lee JE, Gershenwald JE. Randomized Controlled Trial of a Sun Protection Intervention for Children of Melanoma Survivors. Cancer Epidemiology, Biomarkers & Prevention: A Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology. 2013; doi:10.1158/1055-9965. Gritz ER, Tripp MK, Peterson SK, Prokhorov AV, Shete SS, Urbauer DL, Fellman BM, J Lee JE, Gershenwald JE. Randomized Controlled Trial of a Sun Protection Intervention for Children of Melanoma Survivors. Cancer Epidemiology, Biomarkers & Prevention: A Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology. 2013; doi:10.​1158/​1055-9965.
15.
Zurück zum Zitat Geller AC, Emmons KE, Brooks DR, Powers C, Zhang Z, Koh HK, et al. A randomized trial to improve early detection and prevention practices among siblings of melanoma patients. Cancer. 2006. doi:10.1002/cncr.22050. Geller AC, Emmons KE, Brooks DR, Powers C, Zhang Z, Koh HK, et al. A randomized trial to improve early detection and prevention practices among siblings of melanoma patients. Cancer. 2006. doi:10.​1002/​cncr.​22050.
18.
Zurück zum Zitat Novilla MLB, Barnes MD, Natalie G, Williams PN, Rogers J. Public health perspectives on the family: an ecological approach to promoting health in the family and community. Family Commun Health. 2006;29(1):28–42.CrossRef Novilla MLB, Barnes MD, Natalie G, Williams PN, Rogers J. Public health perspectives on the family: an ecological approach to promoting health in the family and community. Family Commun Health. 2006;29(1):28–42.CrossRef
20.
Zurück zum Zitat Geller 23296633 pulls up oliviera reference #13. The paper references #20 with respect to poor communication among family members about family risk. Geller 23296633 pulls up oliviera reference #13. The paper references #20 with respect to poor communication among family members about family risk.
21.
Zurück zum Zitat Cappelli M et al. Psychological and social predictors of decisions about genetic testing for breast cancer in high-risk women. Psychol, Health Med. 2001;6(3):321–33.CrossRef Cappelli M et al. Psychological and social predictors of decisions about genetic testing for breast cancer in high-risk women. Psychol, Health Med. 2001;6(3):321–33.CrossRef
22.
Zurück zum Zitat Friedman LC, Webb JA, Everett TE. Psychosocial and medical predictors of colorectal cancer screening among low-income medical outpatients. J Cancer Educ. 2004;19(3):180–6.CrossRefPubMed Friedman LC, Webb JA, Everett TE. Psychosocial and medical predictors of colorectal cancer screening among low-income medical outpatients. J Cancer Educ. 2004;19(3):180–6.CrossRefPubMed
23.
Zurück zum Zitat McCaul KD et al. What is the relationship between breast cancer risk and mammography screening? A meta-analytic review. Health Psychol. 1996;15(6):423–9.CrossRefPubMed McCaul KD et al. What is the relationship between breast cancer risk and mammography screening? A meta-analytic review. Health Psychol. 1996;15(6):423–9.CrossRefPubMed
24.
Zurück zum Zitat Anton-Culver H et al. The cancer genetics network: recruitment results and pilot studies. Commun Genet. 2003;6(3):171–7.CrossRef Anton-Culver H et al. The cancer genetics network: recruitment results and pilot studies. Commun Genet. 2003;6(3):171–7.CrossRef
25.
Zurück zum Zitat Bowen DJ, Hay JL, Mayer J, Kuniyuki A, Meischke H, Harris J, et al. Predictors of recruited melanoma families into a behavioral intervention project. Contemp Clin Trials. 2012;33(1):85–92.PubMedCentralCrossRefPubMed Bowen DJ, Hay JL, Mayer J, Kuniyuki A, Meischke H, Harris J, et al. Predictors of recruited melanoma families into a behavioral intervention project. Contemp Clin Trials. 2012;33(1):85–92.PubMedCentralCrossRefPubMed
26.
Zurück zum Zitat Bowen DJ, Christensen CL, Powers D, Graves DR, Anderson CAM. Effects of counseling and ethnic identity on perceived risk and cancer worry in African American women. J Clin Psychol Med Settings. 1998;5:365–80.CrossRef Bowen DJ, Christensen CL, Powers D, Graves DR, Anderson CAM. Effects of counseling and ethnic identity on perceived risk and cancer worry in African American women. J Clin Psychol Med Settings. 1998;5:365–80.CrossRef
27.
Zurück zum Zitat Bowen DJ, Burke W, McTiernan A, Powers D, Durfy S, Gralow J, et al. Participation in breast cancer risk counseling among women with a history of cancer. Cancer Epidemiol Biomarkers Prev. 1999;8:581–6. PMID: 1042819.PubMed Bowen DJ, Burke W, McTiernan A, Powers D, Durfy S, Gralow J, et al. Participation in breast cancer risk counseling among women with a history of cancer. Cancer Epidemiol Biomarkers Prev. 1999;8:581–6. PMID: 1042819.PubMed
28.
Zurück zum Zitat Bowen DJ, Powers D, Greenlee H. Effects of breast cancer risk counseling for sexual minority women. Health Care Women Int. 2005;27:59–74.CrossRef Bowen DJ, Powers D, Greenlee H. Effects of breast cancer risk counseling for sexual minority women. Health Care Women Int. 2005;27:59–74.CrossRef
29.
Zurück zum Zitat Bowen DJ, Powers DM. Effects of a mail/telephone intervention on breast health behaviors. Health Educ Behav. 2010;37(4):479–89.CrossRefPubMed Bowen DJ, Powers DM. Effects of a mail/telephone intervention on breast health behaviors. Health Educ Behav. 2010;37(4):479–89.CrossRefPubMed
32.
Zurück zum Zitat Oh SS, Mayer JA, Lewis EC, Slymen DJ, Sallis JF, Elder JP, et al. Validating outdoor workers’ self-report of sun protection. Prev Med. 2004;39(4):798–803.CrossRefPubMed Oh SS, Mayer JA, Lewis EC, Slymen DJ, Sallis JF, Elder JP, et al. Validating outdoor workers’ self-report of sun protection. Prev Med. 2004;39(4):798–803.CrossRefPubMed
33.
Zurück zum Zitat Lerman C, Daly M, Masny A, Balshem A. Attitudes about genetic testing for breast-ovarian cancer susceptibility. J Clin Oncol. 1994;12(4):843–50.PubMed Lerman C, Daly M, Masny A, Balshem A. Attitudes about genetic testing for breast-ovarian cancer susceptibility. J Clin Oncol. 1994;12(4):843–50.PubMed
35.
Zurück zum Zitat Manne S, Jacobsen PB, Ming ME, Winkel W, Dessureault S, Lessin SR. Tailored versus generic interventions for skin cancer risk reduction for family members of melanoma patients. Health Psychol: Off J Div Health Psychol, Am Psychol Assoc. 2010. doi:10.1037/a0021387. Manne S, Jacobsen PB, Ming ME, Winkel W, Dessureault S, Lessin SR. Tailored versus generic interventions for skin cancer risk reduction for family members of melanoma patients. Health Psychol: Off J Div Health Psychol, Am Psychol Assoc. 2010. doi:10.​1037/​a0021387.
37.
Zurück zum Zitat Lowery JT, Horick N, Kinney AY, Finkelstein DM, Garrett K, Haile RW, et al. A randomized trial to increase colonoscopy screening in members of high-risk families in the colorectal cancer family registry and cancer genetics network. Cancer Epidemiol Biomark Prev. 2014. doi:10.1158/1055-9965.EPI-13-1085. Lowery JT, Horick N, Kinney AY, Finkelstein DM, Garrett K, Haile RW, et al. A randomized trial to increase colonoscopy screening in members of high-risk families in the colorectal cancer family registry and cancer genetics network. Cancer Epidemiol Biomark Prev. 2014. doi:10.​1158/​1055-9965.​EPI-13-1085.
38.
Zurück zum Zitat Torres SM, Ramos M, Leverence R, Bowen D, Berwick M, Hay J. A pilot study of skin cancer risk reduction behaviors, cancer communications, and skin cancer beliefs in Hispanics in a Southwestern primary care practice. Californian Journal of Health Promotion. 12:1; 95–100. Torres SM, Ramos M, Leverence R, Bowen D, Berwick M, Hay J. A pilot study of skin cancer risk reduction behaviors, cancer communications, and skin cancer beliefs in Hispanics in a Southwestern primary care practice. Californian Journal of Health Promotion. 12:1; 95–100.
Metadaten
Titel
Effects of web-based intervention on risk reduction behaviors in melanoma survivors
verfasst von
Deborah J. Bowen
Wylie Burke
Jennifer L. Hay
Hendrika Meischke
Julie N Harris
Publikationsdatum
01.06.2015
Verlag
Springer US
Erschienen in
Journal of Cancer Survivorship / Ausgabe 2/2015
Print ISSN: 1932-2259
Elektronische ISSN: 1932-2267
DOI
https://doi.org/10.1007/s11764-014-0412-0

Weitere Artikel der Ausgabe 2/2015

Journal of Cancer Survivorship 2/2015 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.